Delivery Order SPE2DB22D1103-SPE2DB25FH1E0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nitrofurantoin 25 mg/5 ml suspension in a 230 ml quantity, with a ceiling value of $6,907.65. This contract represents a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and carries no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to the place of performance in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Nitrofurantoin 25 mg/5 ml suspension in a 230 ml quantity, valued at $3,014.36. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among qualified vendors in the...
- The Department of Defense's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $19,431.42 for Nitrofurantoin 25 mg/5 mL suspension (230 mL) on August 5, 2025, with completion expected by August 6, 2025. This is a firm fixed-price, non-set-aside contract with performance occurring at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,649.72 to AmerisourceBergen Drug Corp for the supply of Nitrofurantoin 25 mg/5 mL suspension in a 230 mL quantity. This contract was competitively awarded without a set-aside designation and operates under firm fixed price terms, with an ultimate completion date of August 21, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,189.58 to AmerisourceBergen Drug Corp for Nitrofurantoin 25 mg/5 ml suspension in a 230 ml quantity, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order was placed under no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Nitrofurantoin is a broad-spectrum antibiotic commonly used to treat urinary tract infections,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Nitrofurantoin Mono-MCR 100 mg tablets (100 count) with a ceiling value of $1,997.80. This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a non-competitive set-aside award for pharmaceutical supplies to support federal medical procurement needs. The place of performance is listed as AmerisourceBergen's corporate office in...
- The Defense Logistics Agency (DLA) awarded a $15,753.54 firm-fixed-price delivery order to Amerisourcebergen Drug Corp for the supply of 4,565,680,262 milliliters of Nitrofurantoin 25 mg/5 ml suspension. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between DLA Troop Support Medical and Amerisourcebergen, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The award does not...
- The Defense Logistics Agency awarded a delivery order valued at $1,083.53 to AmerisourceBergen Drug Corp for the supply of Nitrofurantoin MCR 100 mg capsules (100-count bottles). This competitive award, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, reflects a firm fixed-price transaction with no set-aside designation. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nitrofurantoin 25 mg/5 ml suspension with a ceiling value of $3,033.72. It is a firm fixed-price delivery order contract with an ultimate completion date of April 30, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Nitrofurantoin 25 mg/5 ml suspension in 240 ml bottles. The $15,154.76 firm-fixed-price delivery order contract has a performance period through September 18, 2024 and is not set aside for any specific business type. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH1E0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Nitrofurantoin 25 mg/5 ml suspension in a 230 ml quantity, valued at $9,138.12 under firm fixed price terms. This non-set-aside, competitively awarded contract is classified as a delivery order with an ultimate completion date of August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction fulfilling pharmaceutical procurement requirements within the Defense Health System's medical supply operations. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying a broad portfolio of pharmaceutical products, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems globally. The company's extensive experience fulfilling diverse medical supply requirements through competitive federal contracts demonstrates its capability to meet the Defense Logistics Agency's medical supply chain needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.1k | 8/27/25 |